Center of Excellence in Digestive Diseases and Gastroenterology, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
Chulabhorn International College of Medicine (CICM), Thammasat University, Pathumthani, Thailand.
PLoS One. 2021 Aug 11;16(8):e0255601. doi: 10.1371/journal.pone.0255601. eCollection 2021.
Gastric intestinal metaplasia (IM) can lead to gastric cancer. Until now, there have been limited studies of predictors for regression and progression of IM. This study aimed to determine risk factors associated with regression or progression of IM for guiding proper management and prevention of gastric cancer.
2,025 patients undergoing gastroscopy in Thammasat University Hospital, Thailand were enrolled during September 2017-August 2019. Patients' data including baseline characteristics, laboratory results, and histopathology of gastric biopsies from University medical database were extensively reviewed.
2,025 patients had mean age of 61.3 years and 44.2% were males. Overall H. pylori prevalence was 47.5%. There were 1,551(76.6%) patients with chronic gastritis and 361(17.8%) with IM. Of 400 patients with chronic gastritis having follow-up endoscopy and repeated gastric biopsies, 104(26%) had persistent H. pylori infection and 27(26%) developed IM during mean follow-up time of 24 months. Persistent H. pylori infection was significantly associated with development of IM (OR 3.16, 95%CI 1.56-6.39, p = 0.001). Regression, persistence, and progression of IM were demonstrated in 57.3%, 39.2%, and 3.5% of patients, respectively. Age >65 years, persistent H. pylori infection, and diabetes mellitus were significantly associated with persistent IM or progression to dysplasia with OR 2.47(95%CI 1.33-4.61, p = 0.004), OR 2.64(95%CI 1.13-6.18, p = 0.025), and OR 2.54(95%CI 1.16-5.54, p = 0.019), respectively. Patients without H. pylori infection had more IM regression than patients with persistent infection (60.4%vs.39.4%, p = 0.035). Patients with persistent H. pylori infection significantly had higher IM progression to dysplasia (15.2%vs.2.1%; OR 11.15, 95%CI 1.18-105.24, p = 0.035) than noninfected. During 24 months of study, 30 patients (1.5%) were diagnosed with gastric cancer.
Regression of IM could be achieved by successful H. pylori eradication. Persistent H. pylori infection was significantly associated with development and progression of IM to dysplasia. Age >65 years and diabetes mellitus were also significant predictors for IM progression.
胃肠上皮化生(IM)可导致胃癌。到目前为止,关于 IM 消退和进展的预测因素的研究有限。本研究旨在确定与 IM 消退或进展相关的危险因素,以指导适当的管理和预防胃癌。
2017 年 9 月至 2019 年 8 月期间,在泰国玛希隆大学医院接受胃镜检查的 2025 名患者入组。从大学医疗数据库中广泛回顾患者的基线特征、实验室结果和胃活检的组织病理学数据。
2025 名患者的平均年龄为 61.3 岁,44.2%为男性。总体幽门螺杆菌(H. pylori)患病率为 47.5%。1551 名(76.6%)患者患有慢性胃炎,361 名(17.8%)患有 IM。在 400 名患有慢性胃炎并接受随访内镜和重复胃活检的患者中,104 名(26%)患者持续存在 H. pylori 感染,27 名(26%)在平均 24 个月的随访期间发展为 IM。持续的 H. pylori 感染与 IM 的发生显著相关(OR 3.16,95%CI 1.56-6.39,p = 0.001)。在 57.3%、39.2%和 3.5%的患者中分别显示了 IM 的消退、持续存在和进展。年龄>65 岁、持续 H. pylori 感染和糖尿病与持续 IM 或进展为异型增生显著相关,OR 分别为 2.47(95%CI 1.33-4.61,p = 0.004)、2.64(95%CI 1.13-6.18,p = 0.025)和 2.54(95%CI 1.16-5.54,p = 0.019)。无 H. pylori 感染的患者比持续感染的患者更有可能发生 IM 消退(60.4%vs.39.4%,p = 0.035)。持续 H. pylori 感染的患者发生 IM 进展为异型增生的比例显著高于未感染患者(15.2%vs.2.1%;OR 11.15,95%CI 1.18-105.24,p = 0.035)。在 24 个月的研究期间,有 30 名患者(1.5%)被诊断为胃癌。
成功根除 H. pylori 可实现 IM 的消退。持续的 H. pylori 感染与 IM 的发展和进展为异型增生显著相关。年龄>65 岁和糖尿病也是 IM 进展的重要预测因素。